|
End-of-day quote
Nasdaq Riga
|
||
| - LVL | - |
|
| 07/01/22 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 06/01/22 | Notification about results of final buy-back of shares | AQ |
| 30/12/21 | Notification about final share buy-back | AQ |
| 28/12/21 | Correction: Regarding results of a share buy-back offer | AQ |
| 28/12/21 | On substantial participation (4) - specified | AQ |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 01/01/2026 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 01/01/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 19/06/2021 | |
Janis Buks
CHM | Chairman | - | 01/09/2022 |
Roberts Tavjevs
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.68% | -2.07% | +15.23% | +66.17% | 47.74B | ||
| -3.21% | +1.37% | +52.36% | +125.75% | 41.7B | ||
| -1.26% | -2.07% | -10.85% | +15.09% | 12.14B | ||
| -0.70% | -3.05% | +11.65% | +68.52% | 11.55B | ||
| 0.00% | 0.00% | +30.00% | +147.62% | 9.18B | ||
| -0.39% | +0.62% | +19.93% | +39.54% | 7.54B | ||
| -1.35% | +0.74% | +47.03% | -11.93% | 7.35B | ||
| -0.84% | -0.26% | +19.14% | +198.35% | 6.88B | ||
| +2.65% | -3.55% | -31.27% | +24.03% | 5.72B | ||
| Average | -0.65% | -0.63% | +17.02% | +74.79% | 16.64B | |
| Weighted average by Cap. | -1.31% | -0.54% | +24.28% | +83.08% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- OLF1R Stock
- OLF1R Stock
Select your edition
All financial news and data tailored to specific country editions
















